Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPCORITAMAB-BYSP vs EPINASTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPCORITAMAB-BYSP vs EPINASTINE: Safety Overview

Metric EPCORITAMAB-BYSP EPINASTINE
Total FAERS Reports 978 843
Deaths Reported 341 6
Death Rate 34.9% 0.7%
Hospitalizations 199 25
Average Patient Age 71.6 yrs 50.0 yrs
% Female Patients 41.6% 66.9%
FDA Approval Date N/A Dec 7, 2016
Manufacturer N/A Somerset Therapeutics, LLC
Route N/A OPHTHALMIC
Marketing Status Prescription Discontinued